University of Oxford
Oxford, Oxfordshire, United Kingdom
Purpose
To enhance the informativeness and impact of the phase 1 study to assess the safety and immunogenicity of an escalating dose malaria vaccine.
Division
Global Health
Date
November 2023
Region Served
AFRICA, AMERICA, ASIA
Committed amount
$57,192
Grant topic
Development of Solutions to Improve Global Health
Duration (months)
11
Grantee location
Oxford, Oxfordshire, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.